Construction and characterization of a recombinant fowlpox virus containing HIV-1 multi-epitope-p24 chimeric gene in mice

Science in China, Series C: Life Sciences

Volumn 50, Issue 2, 2007, Pages 212-220

  Zhang, LiShu ^a   Jin, NingYi ^a   Song, YingJin ^b   Wang, Hong ^c   Ma, HeWen ^d   Li, ZiJian ^e   Jiang, WenZheng ^f  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b TIANJIN UNIVERSITY   (China)

^c JINAN UNIVERSITY   (China)

^d OKLAHOMA STATE UNIVERSITY   (United States)

^e PEKING UNIVERSITY   (China)

^f EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

Fowlpox virus; HIV 1; Immune response; Multi epitope; Recombinant

Indexed keywords

CHIMERIC PROTEIN; GAG PROTEIN; PRIMER DNA; VIRUS ANTIBODY;

ANIMAL; ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; FOWLPOX VIRUS; GENE TRANSFER; GENE VECTOR; GENETIC RECOMBINATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LYMPHOCYTE COUNT; MOUSE; POLYMERASE CHAIN REACTION; SPLEEN; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, VIRAL; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DNA PRIMERS; FOWLPOX VIRUS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HIV CORE PROTEIN P24; HIV-1; LYMPHOCYTE COUNT; MICE; MUTANT CHIMERIC PROTEINS; POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC; SPLEEN; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

FOWLPOX VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MUS;

EID: 34247365905     PISSN: 10069305     EISSN: 18622798     Source Type: Journal    
DOI: 10.1007/s11427-007-0017-1     Document Type: Article

References (27)

1. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol, 1994, 68: 6103-6110
2. Musey L J, Hughes T, Schacker T, et al. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med, 1997, 337: 1267-1274
3. Novitsky V, Smith U R, Gilbert P, et al. Human immunodeficiency virus type 1 subtype C molecular phylogeny: Consensus sequence for an AIDS vaccine design? J Virol, 2002, 76 (11): 5435-5451
4. Williamson A L, Marais D, Passmore J A, et al., Human papilloma virus (HPV) infection in Southern Africa: Prevalence, immunity, and vaccine prospects. IUBMB Life, 2002, 53 (4-5): 253-258
5. Mashishi T, Loubser S, Hide W, et al. Conserved domains of subtype C Nef from South African HIV type 1-infected individuals include cytotoxic T lymphocyte epitope-rich regions. AIDS Res Hum Retroviruses, 2001, 17 (17): 1681-1687
6. Li Z J, Jin N Y, Jiang W Z, et al. A new type of multiple-epitope DNA vaccine against HIV. Chin J Microbiol Immunol (in Chinese), 2004, 24 (11): 910-913
7. Wang H W, Jin N Y, Liu Z, et al. Preparation and identification of the anti-HIV-1 core protein monoclonal antibody. Chin J Cell Mol Immunol (in Chinese), 1998, 14 (1): 63-64
8. Sambrook J, Russell D W. Molecular Cloning: A Laboratory Manual. 3rd ed. New York: Cold Spring Harbor Laboratory Press, 2001. 1.31-1.162
9. Olive C, Toth I, Jackson D. Technological advances in antigen delivery and synthetic peptide vaccine developmental strategies. Mini Rev Med Chem, 2001, 1: 429-438
10. Jackson D, Purcell A, Fitzmaurice C, et al. The central role played by peptides in the immune response and the design of peptide-based vaccines against infectious diseases and cancer. Curr Drug Targets, 2002, 3: 175-196
11. Sciutto E, Fragoso G, Manoutcharian K, et al. New approaches to improve a peptide vaccine against porcine Taenia solium cysticercosis. Arch Med Res, 2002, 33: 371-378
12. Gedvilaite A, Frommel C, Sasnauskas K, et al. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polymavirus major capsid protein. Virology, 2000, 273: 21-35
13. Zhang L S, Jin N Y, Song Y J, et al. Immune responses of a designed HIV-1 DNA vaccine on rhesus monkeys. Chin Sci Bull, 2006, 51 (13): 1571-1577
14. Butter C, Sturman T D, Baaten B J, et al. Protection from infectious bursal disease virus (IBDV)-induced immunosuppression by immunization with a fowlpox recombinant containing IBDV-VP2. Avian Pathol, 2003, 32(6): 597-604
15. Qiao C L, Yu K Z, Jiang Y P, et al. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathol, 2003, 32(1): 25-32
16. Karaca K, Sharma J M, Winslow B J, et al. Recombinant fowlpox viruses coexpressing chicken type I IFN and Newcastle disease virus HN and F genes: Influence of IFN on protective efficacy and humoral responses of chickens following in ovo- or post-hatch administration of recombinant viruses. Vaccine, 1998, 16(16): 1496-1503
17. Mehdy Elahi S, Bergeron J, Nagy E, et al. Induction of humoral and cellular immune responses in mice by a recombinant fowlpox virus expressing the E2 protein of bovine viral diarrhea virus. FEMS Microbiol Lett, 1999, 171(2): 107-114
18. Zhao H L, Jin N Y, Guo Z R, et al. Construction and identification of recombinant fowlpox virus expressing rabies virus glycoprotein. Chin J Vet Sci (in Chinese), 2004, 24(1): 37-39
19. Jin N Y, Zhang H Y, Yin G F, et al. Construction and immunogenecity of a recombinant fowlpox virus co-expressing FMDV P1-2A and 3Cpro gene. Chin Sci Bull, 2004, 49(6): 576-579
20. + T cell immune responses and protection elicited against plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus. J Immunol, 2004, 172(5): 3094-3100
21. Tsang K Y, Palena C, Yokokawa J, et al. Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory molecules. Clin Cancer Res, 2005, 11(4): 1597-1607
22. Hutchings C L, Gilbert S C, Hill A V, et al. Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunity. J Immunol, 2005, 175(1): 599-606
23. Pamungkas J, De Rose R, Iskandriati D, et al. Comparison of whole gene and whole virus scrambled antigen approaches for DNA prime and fowlpox virus boost HIV type 1 vaccine regimens in macaques. AIDS Res Hum Retroviruses, 2005, 21(4): 292-300
24. Parks R J, Krell P J, Derbyshire J B, et al. Studies of fowlpox virus recombination in the generation of recombinant vaccines. Virus Res, 1994, 32(3): 283-297
25. + cytotoxicity T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol, 1994, 68: 6103-6110
26. ?DR-phenotype: Comparison of statistical methods for measurement. J Acquir Immune Defic Syndr, 1999, 22 (1): 19-30
27. Romagnani S. The Th1/Th2 paradigm. Immunol Today, 1997, 18(6): 263-267